A missed proteome in living organisms: A hyppo system

Current Proteomics

Volumn 3, Issue 2, 2006, Pages 129-146

  Seong, Seung Yong ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Antigen presenting cell; DAMP; HHS; Hydrophobicity; Hyppo; Inflammation; Innate immunity; PAMP

Indexed keywords

BACTERIA (MICROORGANISMS); EUKARYOTA;

EID: 33748466701     PISSN: 15701646     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016406778194644     Document Type: Review

References (177)

1. Aiba, S. and Tagami, H. (1999). Dendritic cells play a crucial role in innate immunity to simple chemicals. J. Investig. Dermatol. Symp. Proc. 4: 158-63.
2. Anfinsen, C.B., Haber, E., Sela, M. and White, F.H., Jr. (1961). The kinetics of formation of native ribonuclease during oxidation of the reduced polypeptide chain. Proc. Natl. Acad. Sci. USA 47: 1309-14.
3. Arlaud, G.J., Gaboriaud, C., Thielens, N.M., Rossi, V., Bersch, B., Hernandez, J.F. and Fontecilla-Camps, J.C. (2001). Structural biology of C1: dissection of a complex molecular machinery. Immunol. Rev. 180: 136-45.
4. Aurell, C.A. and Wistrom, A.O. (1998). Critical aggregation concentrations of gram-negative bacterial lipopolysaccharides (LPS). Biochem. Biophys. Res. Commun. 253: 119-23.
5. Barrow, C.J., Yasuda, A., Kenny, P.T. and Zagorski, M.G. (1992). Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J. Mol. Biol. 225: 1075-93.
6. Beamer, L.J., Carroll, S.F. and Eisenberg, D. (1997). Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science 276: 1861-4.
7. Bergner, A., Oganessyan, V., Muta, T., Iwanaga, S., Typke, D., Huber, R. and Bode, W. (1996). Crystal structure of a coagulogen, the clotting protein from horseshoe crab: a structural homologue of nerve growth factor. EMBO J. 15: 6789-97.
8. Bernard, A., Lamy, L. and Alberti, I. (2002). The two-signal model of T-cell activation after 30 years. Transplantation 73: S31-5.
9. Bessler, W.G. and Ottenbreit, B.P. (1976). Studies on the mitogenic principle of the lipoprotein from the outer membrane of Escherichia coli. Biochem. Biophys. Res. Commun. 76: 239-46.
10. Bhat, N., Perera, P.Y., Carboni, J.M., Blanco, J., Golenbock, D.T., Mayadas, T.N. and Vogel, S.N. (1999). Use of a photoactivatable taxol analogue to identify unique cellular targets in murine macrophages: identification of murine CD18 as a major taxol-binding protein and a role for Mac-1 in taxol-induced gene expression. J. Immunol. 162: 7335-42.
11. Biesert, L., Scheuer, W. and Bessler, W.G. (1987). Interaction of mitogenic bacterial lipoprotein and a synthetic analogue with mouse lymphocytes. Isolation and characterization of binding proteins. Eur. J. Biochem. 162: 651-7.
12. Blostein, M.D., Rigby, A.C., Furie, B.C., Furie, B. and Gilbert, G.E. (2000). Amphipathic helices support function of blood coagulation factor IXa. Biochemistry 39: 12000-16.
13. Bonvallot, V., Baeza-Squiban, A., Baulig, A., Brulant, S., Boland, S., Muzeau, F., Barouki, R. and Marano, F. (2001). Organic compounds from diesel exhaust particles elicit a proinflammatory response in human airway epithelial cells and induce cytochrome p450 1A1 expression. Am. J. Respir. Cell Mol.Biol. 25: 515-21.
14. Borst, P., Zelcer, N. and van Helvoort, A. (2000). ABC transporters in lipid transport. Biochim. Biophys. Acta 1486: 128-44.
15. Brightbill, H.D., Libraty, D.H., Krutzik, S.R., Yang, R.B., Belisle, J.T., Bleharski, J.R., Maitland, M., Norgard, M.V., et al. (1999). Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285: 732-6.
16. Casals, C. (2001). Role of surfactant protein A (SP-A)/lipid interactions for SP-A functions in the lung. Pediatr. Pathol. Mol. Med. 20: 249-68.
17. Chen, L. and Sigler, P.B. (1999). The crystal structure of a GroEL/peptide complex: plasticity as a basis for substrate diversity. Cell 99: 757-68.
18. Chen, Z., Hagler, J., Palombella, V.J., Melandri, F., Scherer, D., Ballard, D. and Maniatis, T. (1995). Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev. 9: 1586-97.
19. Chiba, H., Sano, H., Saitoh, M., Sohma, H., Voelker, D.R., Akino, T. and Kuroki, Y. (1999). Introduction of mannose binding protein-type phosphatidylinositol recognition into pulmonary surfactant protein A. Biochemistry 38: 7321-31.
20. Ciechanover, A. (1998). The ubiquitin-proteasome pathway: on protein death and cell life. Embo J. 17: 7151-60.
21. Conti, A., Fortunato, D., Ortolani, C., Giuffrida, M.G., Pravettoni, V., Napolitano, L., Farioli, L.,Perono Garoffo, L., et al. (2001). Determination of the primary structure of two lipid transfer proteins from apricot (Prunus armeniaca). J. Chromatogr. B. Biomed. Sci. Appl. 756: 123-9.
22. Coraci, I.S., Husemann, J., Berman, J.W., Hulette, C., Dufour, J.H., Campanella, G.K., Luster, A.D., Silverstein, S.C., et al., (2002). CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils. Am. J. Pathol. 160: 101-12.
23. Coutant, K.D., de Fraissinette, A.B., Cordier, A. and Ulrich, P. (1999). Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen. Toxicol. Sci. 52: 189-98.
24. da Silva Correia, J., Soldau, K., Christen, U., Tobias, P.S. and Ulevitch, R.J. (2001). Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276: 21129-35.
25. Dahlback, B. (2000). Blood coagulation. Lancet 355: 1627-32.
26. Danforth, J.M., Strieter, R.M., Kunkel, S.L., Arenberg, D.A., VanOtteren, G.M. and Standiford, T.J. (1995). Macrophage inflammatory protein-1 alpha expression in vivo and in vitro: the role of lipoteichoic acid. Clin. Immunol. Immunopathol. 74: 77-83.
27. De Kimpe, S.J., Hunter, M.L., Bryant, C.E., Thiemermann, C. and Vane, J.R. (1995). Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetized rats. Br. J. Pharmacol. 114: 1317-23.
28. Deamer, D.W. (1997). The first living systems: a bioenergetic perspective. Microbiol. Mol. Biol. Rev. 61: 239-61.
29. Devries-Seimon, T., Li, Y., Yao, P.M., Stone, E., Wang, Y., Davis, R.J., Flavell, R. and Tabas, I. (2005). Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor. J. Cell. Biol. 171: 61-73.
30. Dobson, C.M. (2001). The structural basis of protein folding and its links with human disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356: 133-45.
31. Dorner, A.J., Wasley, L.C. and Kaufman, R.J. (1989). Increased synthesis of secreted proteins induces expression of glucose-regulated proteins in butyrate-treated Chinese hamster ovary cells. J. Biol. Chem. 264: 20602-7.
32. Dziarski, R. and Gupta, D. (2005). Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation. Infect. Immun. 73: 5212-6.
33. Epton, M.J., Dilworth, R.J., Smith, W. and Thomas, W.R. (2001). Sensitisation to the lipid-binding apolipophorin allergen Der p 14 and the peptide Mag-1. Int. Arch. Allergy Immunol. 124: 57-60.
34. Feng, B., Yao, P.M., Li, Y., Devlin, C.M., Zhang, D., Harding, H.P., Sweeney, M., Rong, J.X., et al. (2003). The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nat. Cell. Biol. 5: 781-92.
35. Frohlich, J., Westerlund, J., Sparks, D. and Pritchard, P.H. (1990). Familial hypoalphalipoproteinemias. Clin. Invest. Med. 13: 202-10.
36. Furmonaviciene, R., Sutton, B.J., Glaser, F., Laughton, C.A., Jones, N., Sewell, H.F. and Shakib, F. (2005). An attempt to define allergen-specific molecular surface features: a bioinformatic approach. Bioinformatics 21: 4201-4.
37. Garcia-Olmedo, F., Molina, A., Segura, A. and Moreno, M. (1995). The defensive role of nonspecific lipid-transfer proteins in plants. Trends Microbiol. 3: 72-4.
38. Gay, N.J., Packman, L.C., Weldon, M.A. and Barna, J.C. (1991). A leucine-rich repeat peptide derived from the Drosophila Toll receptor forms extended filaments with a beta-sheet structure. FEBS Lett. 291: 87-91.
39. Gershov, D., Kim, S., Brot, N. and Elkon, K.B. (2000). C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. J. Exp. Med. 192: 1353-64.
40. Gething, M.J. (1999). Role and regulation of the ER chaperone BiP. Semin. Cell Dev. Biol. 10: 465-72.
41. Ghosh, P., Hutadilok, N., Adam, N. and Lentini, A. (1994). Interactions of hyaluronan (hyaluronic acid) with phospholipids as determined by gel permeation chromatography, multi-angle laser-light-scattering photometry and 1H-NMR spectroscopy. Int. J. Biol. Macromol. 16: 237-44.
42. Ghuman, J. and Zunszain, P.A., Petitpas, I., Bhattacharya, A.A., Otagiri, M., Curry, S. (2005). Structural basis of the drug-binding specificity of human serum albumin. J. Mol. Biol. 353: 38-52.
43. Gilbert, G.E. and Baleja, J.D. (1995). Membrane-binding peptide from the C2 domain of factor VIII forms an amphipathic structure as determined by NMR spectroscopy. Biochemistry 34: 3022-31.
44. Gilon, T., Chomsky, O. and Kulka, R.G. (1998). Degradation signals for ubiquitin system proteolysis in Saccharomyces cerevisiae. EMBO J. 17: 2759-66.
45. Gilon, T., Chomsky, O. and Kulka, R.G. (2000). Degradation signals recognized by the Ubc6p-Ubc7p ubiquitin-conjugating enzyme pair. Mol. Cell Biol. 20: 7214-9.
46. Girardin, S.E., Tournebize, R., Mavris, M., Page, A.L., Li, X., Stark, G.R., Bertin, J. , DiStefano, P.S., et al. (2001). CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2: 736-42.
47. Goldblum, S.E., Brann, T.W., Ding, X., Pugin, J. and Tobias, P.S. (1994). Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro. J. Clin. Invest. 93: 692-702.
48. Greenberg, C.S., Hammerschmidt, D.E., Craddock, P.R. and Jacob, H.S. (1979). Atheroma cholesterol activates complement and aggregates granulocytes: possible role in ischemic manifestations of atherosclerosis. Trans. Assoc. Am. Physicians. 92: 130-5.
49. Greenow, K., Pearce, N.J. and Ramji, D.P. (2005). The key role of apolipoprotein E in atherosclerosis. J. Mol. Med. 83: 329-42.
50. Groenendyk, J. and Michalak, M. (2005). Endoplasmic reticulum quality control and apoptosis. Acta Biochim. Pol. 52: 381-95.
51. Guiderdoni, E., Cordero, M.J., Vignols, F., Garcia-Garrido, J.M., Lescot, M., Tharreau, D., Meynard, D., Ferriere, N., et al. (2002). Inducibility by pathogen attack and developmental regulation of the rice Ltp1 gene. Plant Mol. Biol. 49: 683-99.
52. Gursky, O. (2005). Apolipoprotein structure and dynamics. Curr. Opin. Lipidol. 16: 287-94.
53. Hailman, E., Lichenstein, H.S., Wurfel, M.M., Miller, D.S., Johnson, D.A., Kelley, M., Busse, L.A., Zukowski, M.M., et al. (1994). Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 179: 269-77.
54. Hailman, E., Albers, J.J., Wolfbauer, G., Tu, A.Y. and Wright, S.D. (1996). Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein. J. Biol. Chem. 271: 12172-8.
55. Hajjar, A.M., O'Mahony, D.S., Ozinsky, A., Underhill, D.M., Aderem, A., Klebanoff, S.J. and Wilson, C.B. (2001). Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J. Immunol. 166: 15-9.
56. Hajjar, A.M., Ernst, R.K., Tsai, J.H., Wilson, C.B. and Miller, S.I. (2002). Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3: 354-9.
57. Halwani, A.E., Niven, D.F. and Dunphy, G.B. (2000). Apolipophorin-III and the interactions of lipoteichoic acids with the immediate immune responses of Galleria mellonella. J. Invertebr. Pathol. 76: 233-41.
58. Hammerschmidt, D.E., Greenberg, C.S., Yamada, O., Craddock, P.R. and Jacob, H.S. (1981). Cholesterol and atheroma lipids activate complement and stimulate granulocytes. A possible mechanism for amplification of ischemic injury in atherosclerotic states. J. Lab. Clin. Med. 98: 68-77.
59. Hauschildt, S., Hoffmann, P., Beuscher, H.U., Dufhues, G., Heinrich, P., Wiesmuller, K.H., Jung, G. and Bessler, W.G. (1990). Activation of bone marrow-derived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis and Ia expression. Eur. J. Immunol. 20: 63-8.
60. Henriksen, A., King, T.P., Mirza, O., Monsalve, R.I., Meno, K., Ipsen, H., Larsen, J.N., Gajhede, M., et al. (2001). Major venom allergen of yellow jackets, Ves v 5: structural characterization of a pathogenesis-related protein superfamily. Proteins 45: 438-48.
61. Hermann, C., Spreitzer, I., Schroder, N.W., Morath, S., Lehner, M.D., Fischer, W., Schutt, C., Schumann, R.R., et al. (2002). Cytokine induction by purified lipoteichoic acids from various bacterial species - role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release. Eur. J. Immunol. 32: 541-51.
62. Hershko, A. and Ciechanover, A. (1998). The ubiquitin system. Annu. Rev. Biochem. 67: 425-79.
63. Hess, D.A. and Rieder, M.J. (1997). The role of reactive drug metabolites in immune-mediated adverse drug reactions. Ann. Pharmacother. 31: 1378-87.
64. Hirschfeld, M., Weis, J.J., Toshchakov, V., Salkowski, C.A., Cody, M.J., Ward, D.C., Qureshi, N., Michalek, S.M., et al. (2001). Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 69: 1477-82.
65. Holmskov, U.L. (2000). Collectins and collectin receptors in innate immunity. APMIS Suppl. 100: 1-59.
66. Hugot, J.P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J.P., Belaiche, J., Almer, S., Tysk, C., et al. (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
67. Huuskonen, J. and Ehnholm, C. (2000). Phospholipid transfer protein in lipid metabolism. Curr. Opin. Lipidol. 11: 285-9.
68. Iakovlev, M., Likhoded, V.G., Anikhovskaia, I.A., Konev Iu, V. and Permiakov, N.K. (1996). Endotoxin-induced injury to the endothelium. Arkh. Patol. 58: 41-5.
69. Inohara, N. and Nunez, G. (2003). NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3: 371-82.
70. IInohara, N., Ogura, Y., Chen, F.F., Muto, A. and Nunez, G. (2001). Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J. Biol. Chem. 276: 2551-4.
71. Inohara, N., Ogura, Y. and Nunez, G. (2002). Nods: a family of cytosolic proteins that regulate the host response to pathogens. Curr. Opin. Microbiol. 5: 76-80.
72. Inohara, N., Chamaillard, M., McDonald, C. and Nunez, G. (2005). NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu. Rev. Biochem. 74: 355-83.
73. Janabi, M., Yamashita, S., Hirano, K., Sakai, N., Hiraoka, H., Matsumoto, K., Zhang, Z., Nozaki, S., et al. (2000). Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler. Thromb. Vasc. Biol. 20: 1953-60.
74. Janeway, C.A., Jr. (1989a). Immunogenicity signals 1,2,3 ... and 0. Immunol. Today 10: 283-6.
75. Janeway, C.A., Jr. (1989b). Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54(Pt 1): 1-13.
76. Kairies, N., Beisel, H.G., Fuentes-Prior, P., Tsuda, R., Muta, T., Iwanaga, S., Bode, W., Huber, R., et al. (2001). The 2.0-A crystal structure of tachylectin 5A provides evidence for the common origin of the innate immunity and the blood coagulation systems. Proc. Natl. Acad. Sci. USA 98: 13519-24.
77. Katayama, T., Imaizumi, K., Manabe, T., Hitomi, J., Kudo, T. and Tohyama, M. (2004). Induction of neuronal death by ER stress in Alzheimer's disease. J. Chem. Neuroanat. 28: 67-78.
78. Kaufman, R.J., Wasley, L.C. and Dorner, A.J. (1988). Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J. Biol. Chem. 263: 6352-62.
79. Kirschning, C.J., Au-Young, J., Lamping, N., Reuter, D., Pfeil, D., Seilhamer, J.J. and Schumann, R.R. (1997). Similar organization of the lipopolysaccharide-binding protein (LBP) and phospholipid transfer protein (PLTP) genes suggests a common gene family of lipid-binding proteins. Genomics 46: 416-25.
80. Kishore, U. and Reid, K.B. (2001). Structures and functions of mammalian collectins. Results Probl. Cell Differ. 33: 225-48.
81. Kishore, U., Wang, J.Y., Hoppe, H.J. and Reid, K.B. (1996). The alpha-helical neck region of human lung surfactant protein D is essential for the binding of the carbohydrate recognition domains to lipopolysaccharides and phospholipids. Biochem. J. 318: 505-11.
82. Kitchens, R.L., Wolfbauer, G., Albers, J.J. and Munford, R.S. (1999). Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. J. Biol. Chem. 274: 34116-22.
83. Kodama, T., Freeman, M., Rohrer, L., Zabrecky, J., Matsudaira, P. and Krieger, M. (1990). Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature 343: 531-5.
84. Krantz, D.D., Zidovetzki, R., Kagan, B.L. and Zipursky, S.L. (1991). Amphipathic beta structure of a leucine-rich repeat peptide. J. Biol. Chem. 266: 16801-7.
85. Krieger, M. (1992). Molecular flypaper and atherosclerosis: structure of the macrophage scavenger receptor. Trends Biochem. Sci. 17: 141-6.
86. Kuroki, Y. and Akino, T. (1991). Pulmonary surfactant protein A (SP-A) specifically binds dipalmitoylphosphatidylcholine. J. Biol. Chem. 266: 3068-73.
87. Lamping, N., Hoess, A., Yu, B., Park, T.C., Kirschning, C.J., Pfeil, D., Reuter, D., Wright, S.D., et al. (1996). Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation. J. Immunol. 157: 4648-56.
88. Laney, J.D. and Hochstrasser, M. (1999). Substrate targeting in the ubiquitin system. Cell 97: 427-30.
89. Lapcik, L., Jr., Lapcik, L., De Smedt, S., Demeester, J. and Chabrecek, P. (1998). Hyaluronan: Preparation, Structure, Properties, and Applications. Chem. Rev. 98: 2663-84.
90. Lashuel, H.A. (2005). Membrane permeabilization: a common mechanism in protein-misfolding diseases. Sci. Aging Knowledge Environ. 2005: pe28.
91. Laskowitz, D.T., Lee, D.M., Schmechel, D. and Staats, H.F. (2000). Altered immune responses in apolipoprotein E-deficient mice. J. Lipid Res.41: 613-20.
92. Leslie, E.M., Deeley, R.G. and Cole, S.P. (2005). Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol. Appl. Pharmacol. 204: 216-37.
93. Lien, E., Chow, J.C., Hawkins, L.D., McGuinness, P.D., Miyake, K., Espevik, T., Gusovsky, F. and Golenbock, D.T. (2001). A novel synthetic acyclic lipid A-like agonist activates cells via the lipopolysaccharide/toll-like receptor 4 signaling pathway. J. Biol. Chem. 276: 1873-80.
94. Lindorff-Larsen, K. and Winther, J.R. (2001). Surprisingly high stability of barley lipid transfer protein, LTP1, towards denaturant, heat and proteases. FEBS Lett. 488: 145-8.
95. Lins, L. and Brasseur, R. (1995). The hydrophobic effect in protein folding. FASEB J. 9: 535-40.
96. Lupu, F., Moldovan, N., Ryan, J., Stern, D. and Simionescu, N. (1993). Intrinsic procoagulant surface induced by hypercholesterolaemia on rabbit aortic endothelium. Blood Coagul. Fibrinolysis 4: 743-52.
97. Madrazo, J., Brown, J.H., Litvinovich, S., Dominguez, R., Yakovlev, S., Medved, L. and Cohen, C. (2001). Crystal structure of the central region of bovine fibrinogen (E5 fragment) at 1.4-A resolution. Proc. Natl. Acad. Sci. USA 98: 11967-72.
98. Mahley, R.W., Nathan, B.P. and Pitas, R.E. (1996). Apolipoprotein E. Structure, function, and possible roles in Alzheimer's disease. Ann. N. Y. Acad. Sci. 777: 139-45.
99. Maier, T., Ferbitz, L., Deuerling, E. and Ban, N. (2005). A cradle for new proteins: trigger factor at the ribosome. Curr. Opin. Struct. Biol. 15: 204-12.
100. Maldonado, A.M., Doerner, P., Dixon, R.A., Lamb, C.J. and Cameron, R.K. (2002). A putative lipid transfer protein involved in systemic resistance signalling in Arabidopsis. Nature 419: 399-403.
101. Mantyjarvi, R., Rautiainen, J. and Virtanen, T. (2000). Lipocalins as allergens. Biochim. Biophys. Acta. 1482: 308-17.
102. Marhaug, G. and Dowton, S.B. (1994). Serum amyloid A: an acute phase apolipoprotein and precursor of AA amyloid. Baillieres Clin. Rheumatol. 8: 553-73.
103. Matzinger, P. (1994). Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12: 991-1045
104. McCormack, F.X. (2001). Functional mapping of surfactant protein A. Pediatr. Pathol. Mol. Med. 20: 293-318.
105. McFadden, J.P. and Basketter, D.A. (2000). Contact allergy, irritancy and 'danger'. Contact Dermatitis 42: 123-7.
106. Means, T.K., Golenbock, D.T. and Fenton, M.J. (2000). Structure and function of Toll-like receptor proteins. Life Sci. 68: 241-58.
107. Medzhitov, R. and Janeway, C., Jr. (2000) The Toll receptor family and microbial recognition. Trends Microbiol. 8: 452-6.
108. Medzhitov, R. and Janeway, C.A., Jr. (1997). Innate immunity: the virtues of a nonclonal system of recognition. Cell 91: 295-8.
109. Minton, A.P. (2000). Implications of macromolecular crowding for protein assembly. Curr. Opin. Struct. Biol. 10: 34-9.
110. Minton, A.P. (2001). The influence of macromolecular crowding and macromolecular confinement on biochemical reactions in physiological media. J. Biol. Chem. 276: 10577-80.
111. Molina, A. and Garcia-Olmedo, F. (1993). Developmental and pathogen-induced expression of three barley genes encoding lipid transfer proteins. Plant J. 4: 983-91.
112. Mortensen, R.F. (2001). C-reactive protein, inflammation, and innate immunity. Immunol. Res. 24: 163-76.
113. Murakami, S., Iwaki, D., Mitsuzawa, H., Sano, H., Takahashi, H., Voelker, D.R., Akino, T. and Kuroki, Y. (2002). Surfactant protein A inhibits peptidoglycan-induced tumor necrosis factor-alpha secretion in U937 cells and alveolar macrophages by direct interaction with toll-like receptor 2. J. Biol. Chem. 277: 6830-7.
114. Muta, T. and Takeshige, K. (2001). Essential roles of CD14 and lipopolysaccharide-binding protein for activation of toll-like receptor (TLR)2 as well as TLR4 Reconstitution of TLR2- and TLR4-activation by distinguishable ligands in LPS preparations. Eur. J. Biochem. 268: 4580-9.
115. Nagai, Y., Akashi, S., Nagafuku, M., Ogata, M., Iwakura, Y., Akira, S., Kitamura, T., Kosugi, A., et al. (2002). Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3: 667-72.
116. Naisbitt, D.J., Gordon, S.F., Pirmohamed, M. and Park, B.K. (2000). Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment. Drug Saf. 23: 483-507.
117. Niere, M., Meisslitzer, C., Dettloff, M., Weise, C., Ziegler, M. and Wiesner, A. (1999). Insect immune activation by recombinant Galleria mellonella apolipophorin III(1). Biochim. Biophys. Acta. 1433: 16-26.
118. Niere, M., Dettloff, M., Maier, T., Ziegler, M. and Wiesner, A. (2001). Insect immune activation by apolipophorin III is correlated with the lipid-binding properties of this protein. Biochemistry 40: 11502-8.
119. Nofer, J.R., Kehrel, B., Fobker, M., Levkau, B., Assmann, G. and Eckardstein, A. (2002). HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 161: 1-16.
120. Obeng, E.A. and Boise, L.H. (2005). Caspase-12 and caspase-4 are not required for caspase-dependent endoplasmic reticulum stress-induced apoptosis. J. Biol. Chem. 280: 29578-87.
121. Ofek, I., Mesika, A., Kalina, M., Keisari, Y., Podschun, R., Sahly, H., Chang, D., McGregor, D., et al. (2001). Surfactant protein D enhances phagocytosis and killing of unencapsulated phase variants of Klebsiella pneumoniae. Infect. Immun. 69: 24-33.
122. Okajima, K. (2001). Regulation of inflammatory responses by natural anticoagulants. Immunol. Rev. 184: 258-74.
123. Olayioye, M.A., Vehring, S., Muller, P., Herrmann, A., Schiller, J., Thiele, C., Lindeman, G.J., Visvader, J.E., et al. (2005). StarD10, a START domain protein overexpressed in breast cancer, functions as a phospholipid transfer protein. J. Biol. Chem. 280: 27436-42.
124. Oparin, A.I. (1961) Life: Its Nature, Origin and Development. Academic Press: New York.
125. Pandya, R.J., Solomon, G., Kinner, A. and Balmes, J.R. (2002). Diesel exhaust and asthma: hypotheses and molecular mechanisms of action. Environ. Health Perspect. 110(Suppl 1): 103-12.
126. Paschen, W. (2004). Endoplasmic reticulum dysfunction in brain pathology: critical role of protein synthesis. Curr. Neurovasc. Res. 1: 173-81.
127. Peiser, L., Gough, P.J., Kodama, T. and Gordon, S. (2000). Macrophage class A scavenger receptor-mediated phagocytosis of Escherichia coli: role of cell heterogeneity, microbial strain, and culture conditions in vitro. Infect. Immun. 68: 1953-63.
128. Pellequer, J.L., Gale, A.J. and Getzoff, E.D. (2000). Blood coagulation: The outstanding hydrophobic residues. Curr. Biol. 10: R237-40.
129. Pereto, J. (2005). Controversies on the origin of life. Int. Microbiol. 8: 23-31.
130. Ponnuraj, K. and Jedrzejas, M.J. (2000). Mechanism of hyaluronan binding and degradation: structure of Streptococcus pneumoniae hyaluronate lyase in complex with hyaluronic acid disaccharide at 1.7 A resolution. J. Mol. Biol. 299: 885-95.
131. Rebeck, G.W., Kindy, M. and LaDu, M.J. (2002). Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3. J. Alzheimers Dis. 4: 145-54.
132. Retzinger, G.S., DeAnglis, A.P. and Patuto, S.J. (1998). Adsorption of fibrinogen to droplets of liquid hydrophobic phases. Functionality of the bound protein and biological implications. Arterioscler. Thromb. Vasc. Biol. 18: 1948-57.
133. Roos, A., Nauta, A.J., Broers, D., Faber-Krol, M.C., Trouw, L.A., Drijfhout, J.W. and Daha, M.R. (2001). Specific inhibition of the classical complement pathway by C1q-binding peptides. J. Immunol. 167: 7052-9.
134. Sahoo, D., Weers, P.M., Ryan, R.O. and Narayanaswami, V. (2002). Lipid-triggered Conformational Switch of Apolipophorin III Helix Bundle to an Extended Helix Organization. J. Mol. Biol. 321: 201-14.
135. Santos, N.C., Silva, A.C., Castanho, M.A., Martins-Silva, J. and Saldanha, C. (2003). Evaluation of lipopolysaccharide aggregation by light scattering spectroscopy. Chembiochem. 4: 96-100.
136. Schroder, M. and Kaufman, R.J. (2005). The mammalian unfolded protein response. Annu. Rev. Biochem. 74: 739-89.
137. Schroder, M., Schafer, R. and Friedl, P. (2002). Induction of protein aggregation in an early secretory compartment by elevation of expression level. Biotechnol. Bioeng. 78: 131-40.
138. Schulthess, G., Compassi, S., Werder, M., Han, C.H., Phillips, M.C. and Hauser, H. (2000). Intestinal sterol absorption mediated by scavenger receptors is competitively inhibited by amphipathic peptides and proteins. Biochemistry 39: 12623-31.
139. Schwarzenbacher, R., Zeth, K., Diederichs, K., Gries, A., Kostner, G.M., Laggner, P. and Prassl, R. (1999). Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO J. 18: 6228-39.
140. Scott, J.E., Cummings, C., Brass, A. and Chen, Y. (1991). Secondary and tertiary structures of hyaluronan in aqueous solution, investigated by rotary shadowing-electron microscopy and computer simulation. Hyaluronan is a very efficient network-forming polymer. Biochem. J. 274: 699-705.
141. Segrest, J.P., Garber, D.W., Brouillette, C.G., Harvey, S.C. and Anantharamaiah, G.M. (1994). The amphipathic alpha helix: a multifunctional structural motif in plasma apolipoproteins. Adv. Protein Chem. 45: 303-69.
142. Seifert, P.S., Hugo, F., Tranum-Jensen, J., Zahringer, U., Muhly, M. and Bhakdi, S. (1990). Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions. J. Exp. Med. 172: 547-57.
143. Seong, S.Y. and Matzinger, P. (2004). Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4: 469-78.
144. Smiley, S.T., King, J.A. and Hancock, W.W. (2001). Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J. Immunol. 167: 2887-94.
145. Smith, K.D., Andersen-Nissen, E., Hayashi, F., Strobe, K., Bergman, M.A., Barrett, S.L., Cookson, B.T. and Aderem, A. (2003). Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat. Immunol. 4: 1247-53.
146. Smith, K.F., Haris, P.I., Chapman, D., Reid, K.B. and Perkins, S.J. (1994). Beta-sheet secondary structure of the trimeric globular domain of C1q of complement and collagen types VIII and X by Fourier-transform infrared spectroscopy and averaged structure predictions. Biochem. J. 301: 249-56.
147. Soccio, R.E. and Breslow, J.L. (2004). Intracellular cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 24: 1150-60.
148. Steinberg, D., Parthasarathy, S., Carew, T.E., Khoo, J.C. and Witztum, J.L. (1989). Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-24.
149. Stevens, F.J. and Argon, Y. (1999). Protein folding in the ER. Semin. Cell Dev. Biol. 10: 443-54.
150. Sugawara, S., Arakaki, R., Rikiishi, H. and Takada, H. (1999). Lipoteichoic acid acts as an antagonist and an agonist of lipopolysaccharide on human gingival fibroblasts and monocytes in a CD14-dependent manner. Infect. Immun. 67: 1623-32.
151. Szaba, F.M. and Smiley, S.T. (2002). Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood 99: 1053-9.
152. Tabel, H. (1996). Alternative pathway of complement in ruminants: role in infection. Vet. Immunol. Immunopathol. 54: 117-21.
153. Takahashi, N., Takahashi, Y. and Putnam, F.W. (1985). Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum. Proc. Natl. Acad. Sci. USA 82: 1906-10.
154. Taskinen, S., Kovanen, P.T., Jarva, H., Meri, S. and Pentikainen, M.O. (2002). Binding of C-reactive protein (CRP) to modified low density lipoprotein (LDL) particles. Identification of unesterified cholesterol as a novel ligand for CRP. Biochem. J. 367:403-12.
155. Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., et al. (2002). Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195: 99-111.
156. Terpstra, V., Bird, D.A. and Steinberg, D. (1998). Evidence that the lipid moiety of oxidized low density lipoprotein plays a role in its interaction with macrophage receptors. Proc. Natl. Acad. Sci. USA 95: 1806-11.
157. Tessitore, A., Del P Martin, M., Sano, R., Ma, Y., Mann, L., Ingrassia, A., Laywell, E.D., Steindler, D.A., et al. (2004). GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Mol. Cell 15: 753-66.
158. Thompson, D., Pepys, M.B. and Wood, S.P. (1999). The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure Fold. Des. 7: 169-77.
159. Turner, M.W. and Hamvas, R.M. (2000). Mannose-binding lectin: structure, function, genetics and disease associations. Rev. Immunogenet. 2: 305-22.
160. Uetrecht, J.P. (2000). Is it possible to more accurately predict which drug candidates will cause idiosyncratic drug reactions? Curr. Drug Metab. 1: 133-41.
161. van de Wetering, J.K., van Eijk, M., van Golde, L.M., Hartung, T., van Strijp, J.A. and Batenburg, J.J. (2001). Characteristics of surfactant protein A and D binding to lipoteichoic acid and peptidoglycan, 2 major cell wall components of gram-positive bacteria. J. Infect. Dis. 184: 1143-51.
162. Van Oosten, M., Rensen, P.C., Van Amersfoort, E.S., Van Eck, M., Van Dam, A.M., Breve, J.J., Vogel, T., Panet, A., et al. (2001). Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis. J. Biol. Chem. 276: 8820-4.
163. Vesy, C.J., Kitchens, R.L., Wolfbauer, G., Albers, J.J. and Munford, R.S. (2000). Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes. Infect. Immun. 68: 2410-7.
164. Virtanen, T. (2001). Lipocalin allergens. Allergy 56(Suppl 67): 48-51.
165. Virtanen, T., Zeiler, T. and Mantyjarvi, R. (1999). Important animal allergens are lipocalin proteins: why are they allergenic? Int. Arch. Allergy Immunol. 120: 247-58.
166. Volanakis, J.E. (2001). Human C-reactive protein: expression, structure, and function. Mol. Immunol. 38: 189-97.
167. Walter, A., Kuehl, G., Barnes, K. and VanderWaerdt, G. (2000). The vesicle-to-micelle transition of phosphatidylcholine vesicles induced by nonionic detergents: effects of sodium chloride, sucrose and urea. Biochim. Biophys. Acta. 1508: 20-33.
168. Wang, J., Sykes, B.D. and Ryan, R.O. (2002). Structural basis for the conformational adaptability of apolipophorin III, a helix-bundle exchangeable apolipoprotein. Proc. Natl. Acad. Sci. USA 99: 1188-93.
169. Wasan, K.M., Ramaswamy, M., Kwong, M. and Boulanger, K.D. (2002). Role of plasma lipoproteins in modifying the toxic effects of water-insoluble drugs: studies with cyclosporine A. AAPS PharmSci. 4: E30.
170. Watford, W.T., Wright, J.R., Hester, C.G., Jiang, H. and Frank, M.M. (2001). Surfactant protein A regulates complement activation. J. Immunol. 167: 6593-600.
171. Werts, C., Tapping, R.I., Mathison, J.C., Chuang, T.H., Kravchenko, V., Saint Girons, I., Haake, D.A., Godowski, P.J., et al. (2001). Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2: 346-52.
172. Wieland, E., Dorweiler, B., Bonitz, U., Lieser, S., Walev, I. and Bhakdi, S. (1999). Complement activation by oxidatively modified low-density lipoproteins. Eur. J. Clin. Invest. 29: 835-41.
173. Wosten, H.A. (2001). Hydrophobins: multipurpose proteins. Annu. Rev. Microbiol. 55: 625-46.
174. Xu, C., Bailly-Maitre, B. and Reed, J.C. (2005). Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest. 115: 2656-64.
175. Yu, B., Hailman, E. and Wright, S.D. (1997). Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J. Clin. Invest. 99: 315-24.
176. Zhou, J., Lhotak, S., Hilditch, B.A. and Austin, R.C. (2005). Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 111: 1814-21.
177. Zwaal, R.F., Comfurius, P. and Bevers, E.M. (1998). Lipid-protein interactions in blood coagulation. Biochim. Biophys. Acta 1376: 433-53.